Debiopharm Innovation Fund
Corporate VCLausanne · Pre-Seed–Late Stage · 13 people tracked
Investment thesis
As Debiopharm's corporate venture arm, the fund backs digital health and health tech startups working to transform pharmaceutical R&D and cancer care. Beyond capital, it offers portfolio companies strategic guidance, deepened market knowledge, pharma expertise, and access to Debiopharm's network, positioning itself as a launchpad for scalable, investment-ready companies aiming to improve outcomes for patients globally.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 11 of 17 portfolio companiesAI & Machine Learning ×7Medical Devices ×7Biotech ×6Healthtech ×6Digital Health ×3SaaS ×3Data & Infrastructure ×2Consumer ×1
HQs:United States×3Belgium×1Switzerland×1Germany×1
Investments · 17 tracked
founders shown can be your intro pathMedaSystems builds a software platform that automates workflows, collects real-world data, and connects physicians with pharmaceutical manufacturers to manage drugs under pre-approval and expanded-access pathways.
Digital HealthHealthtechMedical DevicesSaaSSilicon Valley, US
Brian Irwin(Chief Executive Officer)Jeffrey Thibeault(Chief Technology Officer)
Genialis develops artificial intelligence models trained on ethnically diverse cancer datasets to predict patient responses to targeted therapies and immunotherapies, supporting treatment decisions for pharmaceutical and diagnostic companies.
AI & Machine LearningBiotechMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)Rafael Rosengarten(Chief Executive Officer and Co-founder)Luka Ausec(Executive Officer)Hamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
BoardIta Lu(Director)
Debiopharm is a biopharmaceutical company that develops and manufactures drugs to treat cancer and infectious diseases, and invests in digital health startups.
BiotechDigital HealthMedical DevicesSwitzerland, CH
Rolland-Yves Mauvernay
BoardThierry Mauvernay
ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development.
AI & Machine LearningBiotechMedical Devices
Vedaly provides AI, data analytics, and decision support tools for biopharma companies to integrate insights into scientific and strategic planning.
AI & Machine LearningBiotechData & InfrastructureHealthtechSaaSMartinsried, DE
Tanya Aneichyk(CEO)in
RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines.
AI & Machine LearningHealthtechMedical Devices
SvenBeatMatthias Egger(Professor of Epidemiology)Ingrid(Physician)
Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools.
AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US
Anca Copaescu(Founder)Paulo Carvalho(Executive Officer)Mark Weinstein(Executive Officer, Director)Mark Di Ianni(Executive Officer, Director, Promoter)
BoardRob Hess(Director)Vincent Lepreux(Director)
Tune Insight develops privacy-preserving data collaboration software that combines homomorphic encryption, secure multiparty computation, differential privacy, and federated learning, allowing organizations to derive insights without directly sharing or manipulating raw data.
CybersecurityData & InfrastructureDeep TechDigital HealthHealthtechBelgium, BE
ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology.
AI & Machine LearningBiotechHealthtechMedical Devices
Kenneth To(Chief Executive Officer)Keith Jalbert(Chief Commercial Officer)Christopher Jackson(Chief Scientific Officer)George Hennen(Chief Technology Officer)Rafay Azhar(Medical Director)
WhatsApp is a messaging and calling application that provides text, media, and voice communication services to users across 180+ countries.
ConsumerSocial
Jan KoumBrian Acton
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does Debiopharm Innovation Fund invest at?
- Debiopharm Innovation Fund invests at the Pre-Seed, Seed, Series A, Series B, Late Stage stages.
- What is Debiopharm Innovation Fund's typical check size?
- Debiopharm Innovation Fund typically writes checks of $1M – $5M.
- What sectors does Debiopharm Innovation Fund focus on?
- Debiopharm Innovation Fund focuses on Biotech, Digital Health, Healthtech.
- Where is Debiopharm Innovation Fund located?
- Debiopharm Innovation Fund is headquartered in Lausanne, CH.
- Does Debiopharm Innovation Fund lead rounds?
- Yes, Debiopharm Innovation Fund leads investment rounds.
Media · Podcasts & interviews
featuring the teamFH23 - An interview with Marc Cikes, Managing Director Debiopharm, and Tom Gibbs, Investment Director Debiopharm Innovation Fund
Marc Cikes · vimeo.com
Debiopharm at AACR: First Clinical Data from the MYTHIC Trial (zedoresertib + lunresertib)
DebiopharmTV
Overcoming ADC Linker Challenges: The MultiLINK™ Technology Suite
DebiopharmTV
ADC Talks - Olivier Cochet
DebiopharmTV
ADC Talks - Sophie and Marianna
DebiopharmTV
Antoine’s Journey Finding Purpose at Debiopharm
DebiopharmTV
Images
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Sequoia Capital is a venture capital firm that partners with founders to build technology companies, with a strong current focus on artificial intelligence.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.